HIGHLIGHTS
- who: Georgios Androutsopoulos et al. from the Department of Obstetrics and Gynecology, University of Patras Medical School, Rion, Greece have published the research work: ErbB Receptors and ErbB TargetedTherapies in Endometrial Cancer, in the Journal: (JOURNAL)
- what: The role of ErbB targeted therapies in EC should be further investigated in clinical trials to evaluate their therapeutic efficacy [63]-[65] [71] [74] [87] [90]-[92] [94] [100] [101].
SUMMARY
It has 4 receptors: epidermal growth factor receptor (EGFR or ErbB-1), ErbB-2, ErbB-3 and ErbB-4. According to their affinity . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.